Abstract
Purpose
To determine whether different regimens of multimodal analgesia will reduce postoperative pain scores, opioid consumption, costs and hospital length-of-stay following hip arthroscopy.
Methods
From 2018 to 2021, 132 patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) were included in this prospective, single-center randomized controlled trial. Patients were randomized into four treatment groups:
-
(1)
Group 1—Control: opioid medication (oxycodone-acetaminophen 5 mg/325 mg, 1–2 tabs q6H as needed), Heterotopic ossification prophylaxis—Naprosyn 500 mg twice daily × 3 weeks);
-
(2)
Group 2—Control + postoperative sleeping aid (Zopiclone 7.5 mg nightly × 7 days);
-
(3)
Group 3—Control + preoperative and postoperative Gabapentin (600 mg orally, 1 h preoperatively; 600 mg postoperatively, 8 h following pre-op dose);
-
(4)
Group 4—Control + pre-medicate with Celecoxib (400 mg orally, 1 h preoperatively)
The primary outcome was pain measured with a visual analog scale, monitored daily for the first week and every other day for 6 weeks. Secondary outcomes included opioid consumption, healthcare resource use, and hospital length of stay.
Results
Patient characteristics were similar between groups. There were no statistically significant differences in pain scores between groups at any timepoint after adjusting for intra-operative traction time, intra-operative opioid administration and preoperative pain scores (p > 0.05). There were also no significant differences in the number of days that opioids were taken (n.s.) and the average daily morphine milligram equivalents consumed (n.s.). Similarly, there were no statistically significant differences in length of stay in the experimental groups, compared with the control group (n.s.). Finally, there were no differences in cost between groups (n.s.).
Conclusion
The routine use of Zopiclone, Celecoxib and Gabapentin did not improve postoperative pain control or reduce length-of-stay following hip arthroscopy. Therefore, these medications are not recommended for routine postoperative pain control following hip arthroscopy.
Level of evidence
l.
Similar content being viewed by others
Data availability
The data of this study are available from the corresponding author upon request.
References:
Abebe MM, Arefayne NR, Temesgen MM, Admass BA (2022) Evidence-based perioperative pain management protocol for day case surgery in a resource limited setting: systematic review. Ann Med Surg. https://doi.org/10.1016/j.amsu.2022.104322
Acuña AJ, Jella TK, Samuel LT, Cwalina TB, Kim TS, Kamath AF (2021) A work in progress: national opioid prescription reductions across orthopaedic subspecialties in a contemporary medicare sample of 5,026,911 claims. J Am Acad Orthop Surg Glob Res Rev 5:1–12. https://doi.org/10.5435/JAAOSGlobal-D-21-00080
Bronstone AB, Leonardi C, Kubilay T, Plessl DS, Morreale PJ, Tortorich GM, Krause PC (2022) Dramatic reduction in opioid prescribing for common outpatient orthopaedic lower extremity surgical procedures at a Louisiana University-Based Safety-Net Hospital after enactment of opioid-limiting state legislation. J Am Acad Orthop Surg 30:e405–e414. https://doi.org/10.5435/JAAOS-D-21-00390
Cunningham DJ, George SZ, Lewis BD (2020) The impact of state level public policy, prescriber education, and patient factors on opioid prescribing in elective orthopedic surgery: findings from a tertiary, academic setting. Mayo Clin Proc Innov Qual Outcomes 5:23–34
Cunningham DJ, Kwon NF, Allen NB, Hanselman AM, Adams SB (2021) Time and state legislation have decreased opioid prescribing in elective foot and ankle surgery in the United States. Foot Ankle Spec. https://doi.org/10.1177/19386400211043361
Dold AP, Murnaghan L, Xing J, Abdallah FW, Brull R, Whelan DB (2014) Preoperative femoral nerve block in hip arthroscopic surgery: a retrospective review of 108 consecutive cases. Am J Sports Med 42:144–149
Ekman EF, Wahba M, Ancona F (2006) Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo-controlled study. Arthroscopy 22:635–642
Garner M, Alsheemeri Z, Sardesai A, Khanduja V (2017) A prospective randomized controlled trial comparing the efficacy of fascia iliaca compartment block versus local anesthetic infiltration after hip arthroscopic surgery. Arthroscopy 33:125–132
Huang Y-M, Wang C-M, Wang C-T, Lin W-P, Horng L-C, Jiang C-C (2008) Perioperative celecoxib administration for pain management after total knee arthroplasty—a randomized, controlled study. BMC Musculoskelet Disord. https://doi.org/10.1186/1471-2474-9-77
Jones CA, Throckmorton TW, Murphy J, Eason RR, Joyce M, Bernholt DL, Azar FM, Brolin TJ (2022) Opioid-sparing pain management protocol after shoulder arthroplasty results in less opioid consumption and higher satisfaction: a prospective, randomized controlled trial. J Shoulder Elbow Surg 31:2057–2065
Kahlenberg CA, Patel RM, Knesek M, Tjong VK, Sonn K, Terry MA (2017) Efficacy of Celecoxib for early postoperative pain management in hip arthroscopy: a prospective randomized placebo-controlled study. Arthroscopy 33:1180–1185
Kay J, De Sa D, Memon M, Simunovic N, Paul J, Ayeni OR (2016) Examining the role of perioperative nerve blocks in hip arthroscopy: a systematic review. Arthroscopy 32:704–715
Kumar V, Kaur K, Gupta GK, Gupta AK, Kumar S (2013) Developments in synthesis of the anti-inflammatory drug, celecoxib: a review. Recent Pat Inflamm Allergy Drug Discov 7:124–134
Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL (2021) Morbidity and mortality weekly report trends and geographic patterns in drug and synthetic opioid overdose deaths-United States, 2013–2019. Morb Mortal Wkly Rep 70:202–207
Ménigaux C, Adam F, Guignard B, Sessler DI, Chauvin M (2005) Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery. Anesth Analg 100:1394–1399
NO PAin Investigators, Gazendam A, Ekhtiari S, Horner NS, Simunovic N, Khan M, de Sa DL, Madden K, Ayeni OR (2022) Effect of a postoperative multimodal opioid-sparing protocol vs standard opioid prescribing on postoperative opioid consumption after knee or shoulder arthroscopy: a randomized clinical trial. JAMA 328:1326–1335
Nye ZB, Horn JL, Crittenden W, Abrahams MS, Aziz MF (2013) Ambulatory continuous posterior lumbar plexus blocks following hip arthroscopy: a review of 213 cases. J Clin Anesth 25:268–274
O’Hagan ET, Hübscher M, Miller CB, Gordon CJ, Gustin S, Briggs N, McAuley JH (2020) Zolpidem reduces pain intensity postoperatively: a systematic review and meta-analysis of the effect of hypnotic medicines on post-operative pain intensity. Syst Rev. https://doi.org/10.1186/s13643-020-01458-8
Olsen MF, Bjerre E, Hansen MD, Hilden J, Landler NE, Tendal B, Hróbjartsson A (2017) Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain. BMC Med. https://doi.org/10.1186/s12916-016-0775-3
Pasqualini I, Rullán PJ, Deren M, Krebs VE, Molloy RM, Nystrom LM, Piuzzi NS (2023) Team approach: use of opioids in orthopaedic practice. JBJS Rev. https://doi.org/10.2106/JBJS.RVW.22.00209
Paul RW, Szukics PF, Brutico J, Tjoumakaris FP, Freedman KB (2022) Postoperative multimodal pain management and opioid consumption in arthroscopy clinical trials: a systematic review. Arthrosc Sport Med Rehabil 4:e721–e746
Peng C, Li C, Qu J, Wu D (2017) Gabapentin can decrease acute pain and morphine consumption in spinal surgery patients. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000006463
Randall DJ, Vanood A, Jee Y, Moore DD (2022) National and state level opioid-restricting legislation in total joint arthroplasty: a systematic review. J Arthroplasty 37:176–185
Rose MA, Kam PCA (2002) Gabapentin:pharmacology and its use in pain management. Anaesthesia 57:451–462
Rossi MJ (2021) Editorial commentary: opioid sparing through patient education programs is the future for sports medicine and arthroscopic surgery to optimize outcome. Arthroscopy 37:1573–1576
Federal, provincial, and territorial Special Advisory Committee on the epidemic of opioid overdoses. Opioid- and stimulant-related harms in Canada. Public Health Agency of Canada, Ottawa, 2023. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/
Su L, Garcia-Mansilla I, Kelley B, Arshi A, Fabricant PD, Sherman SL, Jones KJ (2022) Clinical outcomes of meniscal allograft transplantation with respect to the minimal clinically important difference. Am J Sports Med 50:3440–3446
Tashjian RZ, Banerjee R, Bradley MP, Alford W, Fadale PD (2006) Zolpidem reduces postoperative pain, fatigue, and narcotic consumption following knee arthroscopy: a prospective randomized placebo-controlled double-blinded study. J Knee Surg 19:105–111
Tompkins M, Plante M, Monchik K, Fleming B, Fadale P (2011) The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients undergoing ACL reconstruction: a randomized controlled clinical trial. Knee Surg Sports Traumatol Arthrosc 19:787–791
Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M (2005) Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 64:29–33
Xing JG, Abdallah FW, Brull R, Oldfield S, Dold A, Murnaghan ML, Whelan DB (2015) Preoperative femoral nerve block for hip arthroscopy. Am J Sports Med 43:2680–2687
YaDeau JT, Tedore T, Goytizolo EA, Kim DH, Green DST, Westrick A, Fan R, Rade MC, Ranawat AS, Coleman SH, Kelly BT (2012) Lumbar plexus blockade reduces pain after hip arthroscopy: a prospective randomized controlled trial. Anesth Analg 115:968–972
Zhang AL, Feeley BT (2018) Editorial commentary: the rise of hip arthroscopy: temporary trend or here to stay? Arthroscopy 34:1831–1832
Zhang Z, Zhu W, Zhu L, Du Y (2014) Efficacy of celecoxib for pain management after arthroscopic surgery of hip: a prospective randomized placebo-controlled study. Eur J Orthop Surg Traumatol 24:919–923
Funding
The authors would like to acknowledge the Lawson Health Research Institute for their support of this research through an Internal Research Fund (#F06-19).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
This study was registered with http://www.clinicaltrials.gov (NCT03351439) and approved by our institutional review board (Western University Health Sciences REB ID# 110350).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Degen, R.M., Firth, A., Sehmbi, H. et al. Multimodal analgesia did not improve post-operative pain scores, reduce opioid consumption or reduce length of stay following hip arthroscopy. Knee Surg Sports Traumatol Arthrosc 31, 4016–4026 (2023). https://doi.org/10.1007/s00167-023-07445-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00167-023-07445-5